News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) Denies Plans to Spin Off Consumer Health-Care Division


7/29/2014 6:54:29 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlaxoSmithKline Plc (GSK), the U.K.’s biggest drug maker, has no plans to spin off its consumer health-care division, a spokesman said today.

While the company won’t rule out the possibility of one day shedding the unit, it’s not currently being considered, said Simon Steel. The Financial Times reported the possibility of a spinoff yesterday.

Glaxo, which sells consumer brands such as Aquafresh toothpaste and Nicorette gum, is forming a joint venture with Novartis AG (NOVN), to create a consumer health company with about 6.5 billion pounds ($11 billion) in annual revenue. Glaxo will have majority control of the new company. The transaction isn’t expected to close until next year.

Hey, check out all the research scientist jobs. Post your resume today!

Read at Bloomberg


comments powered by Disqus
Bloomberg
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES